NBN mutation
|
Solid Tumor
|
NBN mutation
|
Solid Tumor
|
Immunotherapy Sensitive: B - Late Trials
|
Immunotherapy Sensitive: B - Late Trials
|
NBN mutation
|
Small Cell Lung Cancer
|
NBN mutation
|
Small Cell Lung Cancer
|
olaparib Sensitive: C2 – Inclusion Criteria
|
olaparib Sensitive: C2 – Inclusion Criteria
|